Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1992 May;65(5):667–672. doi: 10.1038/bjc.1992.142

Patterns of methylation of the c-myc gene in human colorectal cancer progression.

R M Sharrard 1, J A Royds 1, S Rogers 1, A J Shorthouse 1
PMCID: PMC1977397  PMID: 1586594

Abstract

Over-expression and abnormal intracellular location of the product of the oncogene c-myc in colonic dysplasia and neoplasia may be related to alterations in epigenetic mechanisms controlling the functioning of this gene. We have investigated the methylation patterns of the c-myc oncogene in human colorectal tissue representing various stages of dysplasia and neoplasia, including metastasis to liver, omentum and lymph node. Comparison of normal and neoplastic tissues from the same patient showed a decrease in methylation in a specific CCGG site in the third exon of c-myc through the progression from normal via dysplastic to neoplastic and metastatic tissue. Quantitative analysis revealed that in colonic adenocarcinomas an average of 66.1% and in metastatic deposits 83.1% of the myc gene DNA was hypomethylated at this site, as compared to a value of 9.2% in normal colonic mucosa. Adenomatous polyps showed an average value of 50.5% and hyperplastic polyps, 24.8%. The results suggest that partial hypomethylation of the c-myc gene third exon is associated with cell proliferation, and that deregulation of proliferation may be linked to the high levels of hypomethylation, presumably involving both copies of the gene in some cells, which occur at a relatively early stage in neoplastic progression.

Full text

PDF
667

Images in this article

669Figure 2
on p.669

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barbieri R., Mischiati C., Piva R., Nastruzzi C., Giacomini P., Natali P. G., Gambari R. DNA methylation of the Ha-ras-1 oncogene in neoplastic cells. Anticancer Res. 1989 Nov-Dec;9(6):1787–1791. [PubMed] [Google Scholar]
  2. Bird A. P. CpG-rich islands and the function of DNA methylation. Nature. 1986 May 15;321(6067):209–213. doi: 10.1038/321209a0. [DOI] [PubMed] [Google Scholar]
  3. Cheah M. S., Wallace C. D., Hoffman R. M. Hypomethylation of DNA in human cancer cells: a site-specific change in the c-myc oncogene. J Natl Cancer Inst. 1984 Nov;73(5):1057–1065. [PubMed] [Google Scholar]
  4. Deguchi Y., Negoro S., Kishimoto S. Methylation of c-myc gene changes in human lymphoproliferative diseases. Biosci Rep. 1987 Aug;7(8):637–643. doi: 10.1007/BF01127676. [DOI] [PubMed] [Google Scholar]
  5. Del Senno L., Maestri I., Piva R., Hanau S., Reggiani A., Romano A., Russo G. Differential hypomethylation of the c-myc protooncogene in bladder cancers at different stages and grades. J Urol. 1989 Jul;142(1):146–149. doi: 10.1016/s0022-5347(17)38700-1. [DOI] [PubMed] [Google Scholar]
  6. Dunnick W., Baumgartner J., Fradkin L., Schultz C., Szurek P. Methylation of plasmacytoma c-myc genes. Gene. 1985;39(2-3):287–292. doi: 10.1016/0378-1119(85)90325-7. [DOI] [PubMed] [Google Scholar]
  7. Feinberg A. P., Vogelstein B. Hypomethylation distinguishes genes of some human cancers from their normal counterparts. Nature. 1983 Jan 6;301(5895):89–92. doi: 10.1038/301089a0. [DOI] [PubMed] [Google Scholar]
  8. Freytag S. O. Enforced expression of the c-myc oncogene inhibits cell differentiation by precluding entry into a distinct predifferentiation state in G0/G1. Mol Cell Biol. 1988 Apr;8(4):1614–1624. doi: 10.1128/mcb.8.4.1614. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Goelz S. E., Vogelstein B., Hamilton S. R., Feinberg A. P. Hypomethylation of DNA from benign and malignant human colon neoplasms. Science. 1985 Apr 12;228(4696):187–190. doi: 10.1126/science.2579435. [DOI] [PubMed] [Google Scholar]
  10. Habets G. G., van der Kammen R. A., Scholtes E. H., Collard J. G. Induction of invasive and metastatic potential in mouse T-lymphoma cells (BW5147) by treatment with 5-azacytidine. Clin Exp Metastasis. 1990 Nov-Dec;8(6):567–577. doi: 10.1007/BF00135878. [DOI] [PubMed] [Google Scholar]
  11. Kaneko Y., Shibuya M., Nakayama T., Hayashida N., Toda G., Endo Y., Oka H., Oda T. Hypomethylation of c-myc and epidermal growth factor receptor genes in human hepatocellular carcinoma and fetal liver. Jpn J Cancer Res. 1985 Dec;76(12):1136–1140. [PubMed] [Google Scholar]
  12. Lipsanen V., Leinonen P., Alhonen L., Jänne J. Hypomethylation of ornithine decarboxylase gene and erb-A1 oncogene in human chronic lymphatic leukemia. Blood. 1988 Dec;72(6):2042–2044. [PubMed] [Google Scholar]
  13. Mango S. E., Schuler G. D., Steele M. E., Cole M. D. Germ line c-myc is not down-regulated by loss or exclusion of activating factors in myc-induced macrophage tumors. Mol Cell Biol. 1989 Aug;9(8):3482–3490. doi: 10.1128/mcb.9.8.3482. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Nambu S., Inoue K., Saski H. Site-specific hypomethylation of the c-myc oncogene in human hepatocellular carcinoma. Jpn J Cancer Res. 1987 Jul;78(7):695–704. [PubMed] [Google Scholar]
  15. Ohtsuki T., Nishitani K., Hatamochi A., Yawata Y., Namba M. Analysis of methylation in the c-MYC gene in five human myeloma cell lines. Br J Haematol. 1991 Feb;77(2):172–179. doi: 10.1111/j.1365-2141.1991.tb07973.x. [DOI] [PubMed] [Google Scholar]
  16. Prendergast G. C., Ziff E. B. Methylation-sensitive sequence-specific DNA binding by the c-Myc basic region. Science. 1991 Jan 11;251(4990):186–189. doi: 10.1126/science.1987636. [DOI] [PubMed] [Google Scholar]
  17. Rabbitts T. H., Forster A., Hamlyn P., Baer R. Effect of somatic mutation within translocated c-myc genes in Burkitt's lymphoma. Nature. 1984 Jun 14;309(5969):592–597. doi: 10.1038/309592a0. [DOI] [PubMed] [Google Scholar]
  18. Razin A., Riggs A. D. DNA methylation and gene function. Science. 1980 Nov 7;210(4470):604–610. doi: 10.1126/science.6254144. [DOI] [PubMed] [Google Scholar]
  19. Renzo A., Bouchard L., Mongeau C. J., Bastin M. Effect of CpG-rich sequences in transformation and tumorigenesis by polyomavirus. Oncogene. 1989 Dec;4(12):1469–1475. [PubMed] [Google Scholar]
  20. Solomon E. Molecular genetics. Colorectal cancer genes. Nature. 1990 Feb 1;343(6257):412–414. doi: 10.1038/343412a0. [DOI] [PubMed] [Google Scholar]
  21. Vogelstein B., Fearon E. R., Kern S. E., Hamilton S. R., Preisinger A. C., Nakamura Y., White R. Allelotype of colorectal carcinomas. Science. 1989 Apr 14;244(4901):207–211. doi: 10.1126/science.2565047. [DOI] [PubMed] [Google Scholar]
  22. Weitzman S. A., Lee R. M., Ouellette A. J. Alterations in c-abl gene methylation in cells transformed by phagocyte-generated oxidants. Biochem Biophys Res Commun. 1989 Jan 16;158(1):24–30. doi: 10.1016/s0006-291x(89)80171-8. [DOI] [PubMed] [Google Scholar]
  23. del Senno L., Gambari R., degli Uberti E., Barbieri R., Bernardi F., Buzzoni D., Marchetti G., Pansini G., Perrotta C., Conconi F. c-myc oncogene alterations in human thyroid carcinomas. Cancer Detect Prev. 1987;10(3-4):159–166. [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES